Pharmaceutical Ganciclovir API Raw Material Ganciclovir Sodium Powder Ganciclovir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Ganciclovir
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Ganciclovir
• Name: Ganciclovir Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 82410-32-0
• Mf: C9h13n5o4
• MW: 255.23100
• Density: 1.81 g/cm3
• Melting Point: 250 C
• Boiling Point: 675 C at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 5 Ton/Month

Product Description

Pharmaceutical Ganciclovir Api Raw Material Ganciclovir Sodium Powder Ganciclovir

 

Product Description

Product Details

Product Name	Ganciclovir
CAS No.	82410-32-0
MF	C9H13N5O4
MW	255.23100
Appearance and shape	White powder

Ganciclovir is an antiviral.    It is used to treat infections caused by viruses.
Ganciclovir is used to treat the symptoms of cytomegalovirus (CMV) infection of the eyes in people whose immune system is not working fully.    This includes patients with acquired immune deficiency syndrome (AIDS).    Ganciclovir will not cure this eye infection, but it may help to keep the symptoms from becoming worse.    It is also used to help prevent CMV infection in patients who receive organ or bone marrow transplants, as well as in patients with advanced human immunodeficiency virus (HIV) infection.

Application & Function

Ganciclovir is a parenterally-active antiviral agent indicated for sight- or life-threatening cytomegalovirus (CMV) infections in immunocompromised patients.  Its suppressive effects on bone marrow and renal tubular secretion/absorption are reported to present potential limitations on adjunct therapies involving zidovudine, vincristine, adriamycin and amphotericin B. Recently, the emergence of CMV strains resistant to ganciclovir therapy has been reported.

Specification